Complete lack of transcription factor PDX-1 leads to pancreatic agenesis, while heterozygosity for PDX-1 mutations has been recently noted in some individuals with MaturityOnset Diabetes of the Young and in some individuals with type 2 diabetes. To determine how alterations in PDX-1 affect islet function, we examined insulin secretion and islet physiology in mice with one PDX-1 allele inactivated. PDX-1 (+/-) mice had a normal fasting blood glucose and pancreatic insulin content, but had impaired glucose tolerance and secreted less insulin during glucose tolerance testing. The expression of PDX-1 and glucose transporter-2 (GLUT2) in islets from PDX-1 (+/-) mice was reduced to 68% and 55%, respectively, while glucokinase (GK) expression was not significantly altered. NAD(P)H generation in response to glucose was reduced by 30% in PDX-1 (+/-) mice. By the in situ perfused pancreas technique, PDX-1 (+/-) mice secreted about 45% less insulin when stimulated with 16.7 mM glucose. The K m for insulin release was similar in wild type and PDX-1 (+/-) mice. Insulin secretion in response to 20 mM arginine was unchanged; the response to 10 nM glucagon-like peptide-1 (GLP-1) was slightly increased. However, insulin secretory responses to 10 mM KIC and 20 mM KCl were significantly reduced (by 61% and 66%, respectively). These results indicate that a modest reduction in PDX-1 impairs several events in glucose-stimulated insulin secretion (such as NAD(P)H generation, mitochondrial function, and/or mobilization of intracellular Ca 2+ ) and that PDX-1 is important for normal function of adult pancreatic islets.
INTRODUCTION
The islet transcription factor PDX-1 (also known as IPF-1, IDX-1, STF-1) was originally discovered as an activator of the insulin and somatostatin genes and from developmental work in the frog (1) (2) (3) (4) (5) (6) (7) (8) (9) . Moreover, several laboratories have demonstrated that PDX-1 plays a key role in pancreatic development and that animals and humans lacking PDX-1 have pancreatic agenesis (1) (2) (3) (6) (7) (8) (9) (10) . PDX-1 also regulates transcription of other islet genes such as GLUT2, glucokinase (GK) and islet amyloid polypeptide (IAPP) (1, 2, 9, (11) (12) (13) (14) . How PDX-1 functions in concert with other islet transcription factors and leads to normal pancreatic exocrine and islet development is unknown.
Mutations in PDX-1 lead to abnormalities in islet function and diabetes in humans and mice (1, 9, (15) (16) (17) (18) (19) . Individuals heterozygous for the Pro63fsdelC mutation develop Maturity-Onset Diabetes of the Young (MODY4) and have impaired insulin secretion in response to glucose (19) .
This mutation is thought to reduce PDX-1 activity by creating an alternate internal translation start site that produces a dominant negative isoform of PDX-1 (20) . Some recent reports indicate that mutations in PDX-1 may predispose individuals to late onset type 2 diabetes mellitus (15) (16) (17) 21) .
Similarly in murine models, both conventional and post natal, cell-specific inactivation of one PDX-1 allele lead to impaired glucose tolerance (2, 6, 8, 18) . In addition, Edlund and colleagues demonstrated a striking reduction in GLUT2 expression in the islets of PDX-1 heterozygote mice PDX-1 and insulin secretion detection was performed using an ECL chemiluminescent system (Amersham). The signals for each protein on autoradiographs were quantified by densitometry. Densitometry measurements from three to four separate islet isolations were averaged.
Immunocytochemistry. Pancreatic tissue was rinsed in ice-cold PBS and then fixed in 4.0% paraformaldehyde/0.1 M sodium phosphate buffer for 1.5 -2 hours at room temperature.
After fixation, 5-µm cryosections were mounted on silanized slides. Primary and secondary antibodies were diluted in PBS containing 1% Bovine Serum Albumin (BSA) and 0.1% Triton X-100. The cryosections were blocked with 5% normal donkey serum (Jackson Immunoresearch Laboratories, Inc.) and then incubated with the PDX-1 antiserum (1:5000), the GLUT2 antibody Populations of α, β, and δ cells in the pancreatic islets were quantified by integrated morphometric analysis. Adjacent sections from 3 -6 mouse pancreases were labeled for INS, and double-labeled for GLU and SOM as described above. In digital images of individual islets, the area of INS + , GLU + , and SOM + cells was computed using MetaMorph 4.6 software (Universal Imaging Corporation, Downingtown, PA). The population of each cell type in the islet was then expressed as a percentage of the total area corresponding to INS + , GLU + , and SOM + cells.
Insulin secretion from in situ perfused pancreas. Mouse pancreas was perfused in situ in a humidified and temperature-controlled chamber (37°C) according to the method of BonnevieNielsen et al. with some modifications (25) . After ligating the superior mesenteric artery, the hepatic artery, the splenic artery, the right and left renal arteries, and the aorta just below the diaphragm, the celiac trunk was perfused through a catheter placed in the aorta. The effluents were collected through a catheter placed in the portal vein. The perfusion was maintained at 0. I-human insulin (Diagnostic Products Corporation, Los Angeles, CA). The RIA has a sensitivity (ED 90 ) of 7.5 pg insulin/mL, which converts to 150 pg insulin/mL when using 5 µL mouse plasma/assay tube.
Insulin released during perfusion of the mouse pancreas or extracted from the mouse pancreas with acid alcohol was determined by a second heterospecies specific RIA using insulin antibody coated tubes (INC Pharmaceuticals, Inc., Costa Mesa, CA), in place of the guinea pig anti-rat insulin serum. This RIA has a sensitivity (ED 90 ) of 0.25 ng insulin/mL which converts to 0.25 ng insulin/mL when using 100 µL of pancreatic perfusate/assay tube and 25 ng/mL when using 1 µL of pancreatic extract/assay tube.
Glucagon released during perfusion of mouse pancreas or extracted from the mouse pancreas with acid alcohol was measured by RIA with guinea pig anti-glucagon serum, ). An equilibrium assay with a sensitivity (ED 90 ) of 15 pg glucagon/mL, which converts to 1.5 ng glucagon/mL when using 1 µL of extract/assay tube, was utilized to determine pancreatic glucagon content. A more sensitive disequilibrium glucagon RIA with an ED 90 of 5 pg glucagon/mL, which converts to 25 pg glucagon/mL when using 20 µL of perfusate/assay tube, was employed to measure glucagon in the perfusate.
IAPP or amylin content in mouse pancreatic extracts was determined using a RIA kit from Phoenix Pharmaceuticals, Inc., Mountain View, CA according to the manufacturer's instructions.
Measurement of NAD(P)H response in isolated islets. NAD(P)H imaging was
performed by two-photon excitation microscopy (TPEM) as described previously (26 
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RESULTS
Effect of PDX-1 deficiency on glucose tolerance and insulin secretion in vivo.
Mice with one inactivated allele of PDX-1 have impaired glucose clearance during glucose tolerance testing (Figure 1 ). At 8 weeks of age, the fasting blood glucose levels were not different in the PDX-1 (+/-) and wild type littermates (PDX-1 +/+ males 62 ± 6 mg/dL, n = 5 vs. PDX-1 +/-males 73 ± 6 mg/dL, n = 5 and PDX-1 +/+ females 50 ± 7 mg/dL, n = 5 vs. PDX-1 +/-females 63 ± 4 mg/dL, n = 9). In older mice (16 -25 weeks), the fasting glucose levels increased but they were still statistically insignificant in the male group of mice (PDX-1 +/+ males 78 ± 9 mg/dL, n = 6
vs. PDX-1 +/-males 92 ± 6 mg/dL, n = 13, P = 0.22; and PDX-1 +/+ females 63 ± 7, n = 4 vs.
PDX-1 +/-females 81 ± 4, n = 10, P < 0.05). However, following glucose administration, PDX-1 (+/-) mice had a pronounced and prolonged rise in their blood glucose compared to PDX-1 (+/+) mice and this abnormality became even greater as mice aged (8 weeks old mice in Figure 1a ,d vs. Figure 1b ,e). There was a gender-related difference in the glucose clearance, but both males and females had impaired glucose tolerance. The data from IPGTT showed that 30% of PDX-1 (+/-) males (7/23) and 20% of PDX-1 (+/-) females (4/20) had normal glucose tolerance, however their plasma insulin levels were reduced to the levels similar to those measured in the PDX-1 (+/-) littermates with impaired glucose tolerance ( Figure 1c ). This finding is somewhat similar to the data from human subjects heterozygous for mutations in PDX-1 gene (D76N variant), who had normal plasma glucose levels, however their plasma insulin levels in response to glucose load were significantly lower (16) . More recent data from the study in MODY4 patients (heterozygous for the Pro63fsdelC mutation) also suggests that increased peripheral tissue sensitivity to insulin is a mechanism for maintaining glucose homeostasis in MODY4 individuals (19) . After PDX-1 (+/-) mice were phenotyped by IPGTT, the mice with normal glucose tolerance were not included in studies described below.
-25 week old mice in
Effect of PDX-1 deficiency on islet gene expression. To investigate the mechanism
by which PDX-1 (+/-) mice had lower plasma insulin levels than their wild type littermates, we examined expression of insulin and other islet genes known to be regulated in vitro by PDX-1. As shown in Table 1 , the decrease in insulin secretion in PDX-1 (+/-) mice is not due to reduced pancreatic insulin and suggests an inability of the PDX-1 heterozygotes to respond to (+/-) mice (8) . In contrast, the pancreatic content of glucagon was increased by 29% while the content of IAPP was reduced by 32% in PDX-1-deficient mice (Table 1) .
Immunohistochemical evaluation of pancreases from 16 -18-weeks old PDX-1 (+/-) mice revealed normal islet morphology (Figure 2a -f) and a normal ratio of β to α or δ cells ( Figure 2 ).
However, the expression of glucose transporter GLUT2 was reduced quite dramatically compared to wild-type islets (Figure 2c,d ). Similar changes in GLUT2 expression were seen in 7
week-old mice (data not shown). Ahlgren et al. reported similar decreases in GLUT2 expression in PDX-1 deficient mice (8) . The reduction in GLUT2 expression was somewhat variable from islet to islet and in some islets GLUT2 expression was only slightly reduced. The expression of PDX-1, GLUT2 and GK in isolated islets of PDX-1 (+/-) mice was further evaluated by immunoblot analysis (Figure 2g ). Expression of PDX-1 and GLUT2 was reduced to about 68% and 55%, respectively compared to wild type mice, while GK expression was relatively unchanged.
Molecular events in islet response to glucose.
To define the molecular mechanisms by which PDX-1 deficiency alters glucose-stimulated insulin secretion (GSIS) in pancreatic β cells, the pancreas of PDX-1 (+/+) and PDX-1 (+/-) mice were challenged with a linear glucose gradient ( Figure 3 ) using an in situ pancreas perfusion technique. This technique uses the native vasculature to deliver changes in glucose to the pancreatic islet and avoids the need for enzymatic digestion during islet isolation. While the amount of insulin released after glucose stimulation was less in PDX-1 (+/-) animals, the K m for insulin release in response to the glucose gradient during pancreas perfusion was similar in wild type (12.0 ± 1.3 mM) and heterozygote (8.0 ± 0.4 mM) mice. To further examine molecular events in the GSIS pathway, we examined glucose-induced NAD(P)H responses of isolated islets using TPEM. Islets isolated from PDX-1 (+/+) and PDX-1 (+/-) mice showed a very uniform autofluorescence signal during exposure to 1 mM glucose (Figure 4a ). In the case of wild type islets, this signal was greatly enhanced when glucose was increased from 1 mM to 20 mM (Figure 4b ). However, islets of PDX-1 heterozygotes generated about 30% less NAD(P)H in response to 20 mM glucose compared to islets of wild type mice (Figure 4c ). However, when 20 mM arginine was added to 16.7 mM glucose, the insulin secretion from the pancreas of PDX-1 heterozygotes was greatly reduced (Figure 5a ). The insulin response was decreased by 60%. Since the pancreatic content of glucagon was increased in PDX-1 heterozygotes (Table 1) , we examined glucagon secretion to see if increased glucagon might be inhibiting insulin secretion. In spite of the greater glucagon content in pancreatic extracts, the pancreases of PDX-1 heterozygotes did not secrete significantly more glucagon than wild type mice ( Figure 5b ).
Insulin secretion in response to 10 nM GLP-1 was increased in both PDX-1 (+/-) males and females when compared to their wild type littermates, however the magnitude of insulin response was much greater in the male group of mice ( Figure 6 ). PDX-1 (+/-) males and females released a similar amount of insulin in response to 10 nM glibenclamide as their wild type littermates ( Figure   6 ). On the other hand, insulin secretory responses to both 10 mM KIC and 20 mM KCl were reduced quite significantly in PDX-1 (+/-) mice (by 61% and 66%, respectively) when compared (27) . For example, both humans and mice have pancreatic agenesis and severe diabetes when both alleles of PDX-1 are inactive (1-3,6-10). In the PDX-1 heterozygote mouse model and in non-diabetic humans with a mutation in one PDX-1 allele, the fasting blood glucose is normal but there is impairment in insulin secretion and glucose clearance after glucose administration (8, (16) (17) (18) (19) . PDX-1 heterozygote mice have impaired glucose tolerance as early as 8
weeks of age and the impairment becomes more pronounced as these mice age. This similarity of murine human phenotypes suggests that the current study of the molecular events may provide insight into how reduced PDX-1 leads to impaired insulin secretion in humans.
How do reduced PDX-1 levels impair insulin secretion? Since PDX-1 has an important role in islet formation and insulin gene transcription, one possibility is that PDX-1 deficiency reduces insulin gene transcription and thus reduces insulin output. However, in both the current study and the report by Edlund and co-workers, pancreatic insulin content is normal in mice with one PDX-1 allele inactivated (8) . Thus, while PDX-1 is an important transcription factor for the insulin gene in cell culture systems, sufficient redundancy in other insulin gene transcription factors must compensate for the reduction in PDX-1 in vivo. Similar observations were made in MIN6 cells, where 80 -90% suppression of PDX-1 had no effect on the level of insulin mRNA (28) .
Immunohistochemical examination of the pancreas from 16 -18-week-old PDX-1 heterozygotes showed normal islet morphology and no major alteration in the ratio of β to α or δ cells. Dutta et al.
found that islet size was normal in these mice, but that the number of non-β cells was slightly increased (18) . 
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In order to better understand the pathophysiological basis of impaired glucose tolerance in PDX-1 (+/-) mice, we studied a number of parameters associated with β cell function. It appears that the major factor responsible for the development of impaired glucose tolerance in the PDX-1 (+/-) mice is a reduction in the insulin secretory response to glucose. During pancreas perfusion with 16.7 mM glucose, insulin secretion was reduced substantially in PDX-1 (+/-) animals (~ 55%
of insulin secretory response in wild type littermates). This reduction was even more pronounced when 20 mM arginine was added to 16.7 mM glucose.
A possible explanation for the impaired GSIS in PDX-1 heterozygote mice is that PDX-1 deficiency reduces glucose transport and phosphorylation. Even though the amount of insulin released after glucose stimulation was less in PDX-1 (+/-) animals, the K m for insulin release in response to the glucose gradient during pancreas perfusion was similar in wild type and heterozygote mice. This result and the finding that GK protein expression was not significantly altered in PDX-1 (+/-) mice indicate that GK is still the rate-limiting step in GSIS in PDX-1 (+/-) heterozygote islets. Because the glucose transport capacity of the pancreatic β cells greatly exceeds glucose phosphorylation (29) and because the K m for insulin secretion in our pancreas perfusion studies is not shifted rightward (toward the K m for GLUT2), this suggests that a reduction in GLUT2 is not responsible for the impaired GSIS. In a recent study in GLUT2 null mice, normal GSIS was rescued by GLUT2 expression at only 20% of the level in normal rat islets (30) . These authors also indirectly indicated that there was no difference in the glucose usage and GSIS by islets carrying only one allele of the wild type GLUT2 gene. Human islets express considerably less GLUT2 compared to rodent islets; thus, it is possible that a ~ 50% reduction of GLUT2 in human islets might impact glucose transport sufficiently to impair GSIS 
in the presence, but not absence of glucose (43) , and may be electrogenically transported into the β cell through the cationic amino acid transporter (CAT2) (44, 45) . Uptake of arginine directly depolarizes the β cell membrane and thus elicits Ca 2+ -dependent electrical activity, Ca 2+ entry and insulin secretion (46) . However, arginine may also enhance production of nitric oxide in the β cell and evoke insulin secretion by stimulating guanylyl cyclase and increasing the amount of intracellular guanosine 3', 5'-monophospate (47), which has been suggested to be a mediator of insulin secretion (48) . Thus, K ATP channel-independent stimulus-secretion coupling in the β cell 
